[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100157053":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":7,"locations":17,"responsibleParty":28,"collaborators":32,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":7,"acronym":7,"eligibilityCriteria":41,"healthyVolunteers":38,"sex":42,"minAge":43,"maxAge":7,"enrollmentInfo":44,"targetDuration":7,"studyType":47,"phases":48,"briefSummary":50,"conditions":51,"keywords":7,"overallStatus":53,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"University of Zurich","OTHER",null,[9],{"type":10,"name":11,"description":7,"armGroupLabels":7,"otherNames":7},"DRUG","QAX567",[13],{"name":14,"affiliation":15,"role":16},"01 Studienregister MasterAdmins","UniversitaetsSpital Zuerich","STUDY_DIRECTOR",[18],{"facility":7,"status":7,"city":19,"state":7,"zip":7,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":7},"Zurich","Switzerland","CH",{"type":23,"coordinates":24},"Point",[25,26],8.55,47.36667,{"lat":26,"lon":25},{"type":29,"investigatorFullName":30,"investigatorTitle":31,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"SPONSOR_INVESTIGATOR","Gerhard Rogler","Prof.Dr.Dr. Gerhard Rogler",[33],{"name":34,"class":35},"Novartis Pharmaceuticals","INDUSTRY","100157053","phase-2-a-study-to-assess-efficacy-safety-and-tolerability-of-the-anti-il-13-monoclonal-antibody-qax576-in-the-treatment-of-perinanal-fistulas-in-patients-suffering-from-crohns-disease-100157053",false,"NCT01316601","A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease","Inclusion criteria: - diagnosis of Crohn's disease \\> 6 month with fistula - at least 1 ineffective fistula treatment in the past\n\nExclusion criteria: - TNF a antibody treatment failed in the past\n\n\\- planned surgery","ALL","18 Years",{"count":45,"type":46},3,"ACTUAL","INTERVENTIONAL",[49],"PHASE2","Test safety and efficacy and of a novel IL-13 AB in the treatment of perianal fistulas\n\n* Trial with medicinal product",[52],"Crohn's Disease","COMPLETED","2015-05-27",{"date":56,"type":57},"2015-05-28","ESTIMATED",{"date":59,"type":7},"2011-01",{"date":61,"type":46},"2012-11",{"name":30,"class":6},1]